Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Ruminant Vaccines Market

Ruminant Vaccines Market Share

Report ID: GMI10481
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Ruminant Vaccines Market Share

The ruminant vaccines industry is characterized by significant competition among global players. The market is dominated by major global players such as Zoetis, Inc., Boehringer Ingelheim, Merck & Co., and Elanco Animal Health, which leverage their extensive product portfolios, robust R&D capabilities, and wide distribution networks. Competitive strategies include mergers and acquisitions, strategic partnerships, and ongoing investments in vaccine development and improvements.

Ruminant Vaccines Market Companies

Prominent players operating in the ruminant vaccines industry include:

Bimeda Biologicals
Boehringer Ingelheim International GmbH
Ceva Santé Animale
CZ Vaccines S.A.U. (Zendal Group)
Elanco Animal Health
HIPRA
Indian Immunologicals Ltd.
Kyoto Biken Laboratories, Inc.
Merck & Co., Inc.
Vaxxinova International BV
Virbac
Zoetis, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ruminant vaccines market accounted for USD 1.9 billion in 2023 and is set to register 6.8% CAGR during 2024-2032 driven by the increase in the livestock population.

The attenuated/modified live vaccines segment in the market held 53.2% share in 2023 as they provide quicker protection following vaccination.

North America ruminant vaccines market accounted for USD 744.8 million in 2023 and is expected to reach USD 1.3 billion by 2032 driven by the demand for effective vaccination programs.

Bimeda Biologicals, Boehringer Ingelheim International GmbH, Ceva Santé Animale, CZ Vaccines S.A.U. (Zendal Group), Elanco Animal Health, HIPRA, Indian Immunologicals Ltd., Kyoto Biken Laboratories, Inc., and Merck & Co., Inc. among others.